|
79
|
257
|
5g0bA |
An unusual natural product primary sulfonamide: synthesis, carbonic anhydrase inhibition and protein x-ray structure of psammaplin c |
|
74
|
259
|
4z1eA |
Carbonic anhydrase inhibitors: design and synthesis of new heteroaryl-n-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms (hca vii, hca ix, and hca xiv) |
|
72
|
257
|
4ywpA |
Sucrose binding site in genetically engineered carbonic anhydrase ix |
|
80
|
257
|
5dsnA |
Structure of co2 released holo-form of human carbonic anhydrase ii with 1 hr warming |
|
82
|
258
|
5g0cA |
An unusual natural product primary sulfonamide: synthesis, carbonic anhydrase inhibition and protein x-ray structure of psammaplin c |
|
77
|
257
|
4zwiA |
Surface lysine acetylated human carbonic anhydrase ii in complex with a sulfamate-based inhibitor |
|
79
|
257
|
5g03A |
An unusual natural product primary sulfonamide: synthesis, carbonic anhydrase inhibition and protein x-ray structure of psammaplin c |
|
79
|
257
|
5flpA |
Native state mass spectrometry, surface plasmon resonance and x-ray crystallography correlate strongly as a fragment screening combination |
|
75
|
258
|
5fdcA |
Crystal structure of human carbonic anhydrase ii in complex with the anticonvulsant sulfamide jnj-26990990 and its s,s-dioxide analog. |
|
77
|
258
|
5fnmA |
Native state mass spectrometry, surface plasmon resonance and x-ray crystallography correlate strongly as a fragment screening combination |
|
81
|
258
|
5flqA |
Native state mass spectrometry, surface plasmon resonance and x-ray crystallography correlate strongly as a fragment screening combination |
|
66
|
251
|
5fl6A |
Three dimensional structure of human carbonic anhydrase ix in complex with 5-(1-(4-methylphenyl)-1h-1,2,3-triazol-4-yl)thiophene-2- sulfonamide |
|
79
|
258
|
5fniA |
Native state mass spectrometry, surface plasmon resonance and x-ray crystallography correlate strongly as a fragment screening combination |
|
68
|
251
|
5fl4A |
Three dimensional structure of human carbonic anhydrase ix in complex with 5-(1-naphthalen-1-yl-1,2,3-triazol-4-yl)thiophene-2-sulfonamide |
|
73
|
258
|
4z0qA |
Carbonic anhydrase inhibitors: design and synthesis of new heteroaryl-n-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms (hca vii, hca ix, and hca xiv) |
|
80
|
258
|
5floA |
Native state mass spectrometry, surface plasmon resonance and x-ray crystallography correlate strongly as a fragment screening combination |
|
82
|
258
|
5fnjA |
Native state mass spectrometry, surface plasmon resonance and x-ray crystallography correlate strongly as a fragment screening combination |
|
80
|
258
|
5flsA |
Native state mass spectrometry, surface plasmon resonance and x-ray crystallography correlate strongly as a fragment screening combination |
|
77
|
258
|
5fnkA |
Native state mass spectrometry, surface plasmon resonance and x-ray crystallography correlate strongly as a fragment screening combination |
|
75
|
257
|
5fngA |
Native state mass spectrometry, surface plasmon resonance and x-ray crystallography correlate strongly as a fragment screening combination |
|
78
|
258
|
5fltA |
Native state mass spectrometry, surface plasmon resonance and x-ray crystallography correlate strongly as a fragment screening combination |
|
78
|
258
|
5fdiA |
Crystal structure of human carbonic anhydrase ii with the anticonvulsant sulfamide jnj-26990990 and its s,s-dioxide analog. |
|
80
|
258
|
5fnlA |
Native state mass spectrometry, surface plasmon resonance and x-ray crystallography correlate strongly as a fragment screening combination |
|
77
|
257
|
5fnhA |
Native state mass spectrometry, surface plasmon resonance and x-ray crystallography correlate strongly as a fragment screening combination |
|
78
|
258
|
5flrA |
Native state mass spectrometry, surface plasmon resonance and x-ray crystallography correlate strongly as a fragment screening combination |
|
68
|
251
|
5fl5A |
Three dimensional structure of human carbonic anhydrase ix in complex with 5-(1-(4-methoxyphenyl)-1h-1,2,3-triazol-4-yl)thiophene-2- sulfonamide |
|
77
|
257
|
5ekmA |
Human carbonic anhydrase ii complexed with a two-faced guest |
|
75
|
257
|
5eheA |
Crystal structure of human carbonic anhydrase isozyme ii with 3-(benzylamino)-2,5,6-trifluoro-4-[(2-hydroxyethyl)sulfonyl]benzenesulfonamide |
|
74
|
261
|
5e2rA |
The crystal structure of the human carbonic anhydrase ii in complex with a 1,1'-biphenyl-4-sulfonamide inhibitor |
|
77
|
257
|
5e2kA |
Crystal structure of human carbonic anhydrase ii in complex with the 4-(3-aminophenyl)benzenesulfonamide inhibitor |
|
76
|
257
|
5ekhA |
Human carbonic anhydrase ii complexed with a two-faced guest |
|
73
|
257
|
5eijA |
Carbonic anhydrase ii in complex with sulfonamide inhibitor |
|
62
|
265
|
5e5rA |
Crystal structure of the complex between carbonic anhydrase-like domain of ptprg and immunoglobulin domains 2-3 of cntn3 |
|
78
|
258
|
5e2nA |
Crystal structure of human carbonic anhydrase isozyme xiii with 3-(cyclooctylamino)-2,5,6-trifluoro-4-[(2-hydroxyethyl)sulfonyl]benzenesulfonamide |
|
78
|
257
|
4zaoA |
Genetically engineered carbonic anhydrase ix |
|
78
|
258
|
5eh8A |
Human carbonic anhydrase ii in complex with ligand |
|
75
|
256
|
5eh7A |
Human carbonic anhydrase ii in complex with ligand |
|
77
|
258
|
5e2sA |
Crystal structure of human carbonic anhydrase ii in complex with the 4-(2-iso-propylphenyl)benzenesulfonamide inhibitor |
|
77
|
258
|
5ekjA |
Human carbonic anhydrase ii complexed with a two-faced guest |
|
77
|
258
|
5ehwA |
Human carbonic anhydrase ii in complex with ligand |
|
73
|
264
|
5e5uA |
Crystal structure of the complex between carbonic anhydrase-like domain of ptprg and immunoglobulin domains 2-3 of cntn6 |
|
76
|
256
|
5e2mA |
Crystal structure of human carbonic anhydrase isozyme i with 3-(cyclooctylamino)-2,5,6-trifluoro-4-[(2-hydroxyethyl)sulfonyl]benzenesulfonamide |
|
77
|
258
|
5eoiA |
Crystal structure of copper bound human carbonic anhydrase ii |
|
77
|
258
|
5ehvA |
Human carbonic anhydrase ii in complex with ligand |
|
78
|
256
|
5eh5A |
Human carbonic anhydrase ii in complex with ligand |
|
78
|
257
|
5e28A |
Crystal structure of human carbonic anhydrase ii in complex with the 4-(4-aminophenyl)benzenesulfonamide inhibitor |
|
60
|
256
|
5eztX |
Peracetylated bovine carbonic anhydrase ii |
|
76
|
257
|
5amlA |
Three dimensional structure of human carbonic anhydrase ii in complex with 2-(but-2-yn-1-ylsulfamoyl)-4-sulfamoylbenzoic acid |
|
79
|
257
|
5drsA |
Crystal structure of human carbonic anhydraseisozyme ii with 3-[(1s)-2,3-dihydro-1h-inden-1-ylamino]-2,5,6-trifluoro-4-[(2-hydroxyethyl)sulfonyl]benzenesulfonamide |
|
76
|
257
|
5dsrA |
Structure of co2 released apo-form of human carbonic anhydrase ii with 10 min warming |
